Pertussis Vaccine Market By Product Type, Vaccine Type and End User - Global Industry Analysis And Forecast To 2027
Published On : June 2022 Pages : 172 Category: Pharmaceuticals Report Code : HC063901
Pertussis Vaccine Market By Product Type (Tdap Vaccine and DTaP Vaccine), Vaccine Type (Acellular Vaccine and Whole-Cell Vaccine) and End User (Vaccination Centers, Clinics and Hospitals) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The pertussis antibody is the immunization that protects against the pertussis (whooping cough).There are two primary types: acellular vaccines and whole-cell vaccines. The whooping cough spreads all around with ease from individual to individual. Since it typically begins off like the cold, individuals who have the whooping cough may not realize they are spreading it. What's more, it tends to be deadly, particularly for the infants. Therefore, the Pertussis Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global Pertussis Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drives & Restrains
The factors responsible for growth are; rising number of aged population across the globe, rise in the number of initiatives by the government, increasing adoption of this vaccination, and some other factors. The factor affecting the growth can be alternative treatment option.
Regional Insights
The North American region is leading the global Pertussis Vaccine Market owing to factor like; rise in the number of aged population, rising number of deaths due to pertussis, rising utilization of these vaccines and few other factors.
Pertussis Vaccine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Novartis AG
- Astellas Pharma US, Inc.
- Sanofi Pasteur
- Merck Sharp & Dohme Corp.
- GlaxoSmithKline
- Seqirus
- Protein Sciences Corporation
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Pertussis Vaccine Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Tdap Vaccine
o DTaP Vaccine
o Pertussis Vaccine Market, By Vaccine Type, Estimates and Forecast, 2017-2027 ($Million)
o Acellular Vaccine
o Whole-Cell Vaccine
o Pertussis Vaccine Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Vaccination Centers
o Clinics
o Hospitals
o Pertussis Vaccine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novartis AG
o Astellas Pharma US, Inc.
o Sanofi Pasteur
o Merck Sharp & Dohme Corp.
o GlaxoSmithKline
o Seqirus
o Protein Sciences Corporation
o Pertussis Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Pertussis Vaccine Market, By Country
o U.S. Pertussis Vaccine Market
o Canada Pertussis Vaccine Market
o Mexico Pertussis Vaccine Market
o Europe
§ Europe Pertussis Vaccine Market, By Country
o Germany Pertussis Vaccine Market
o UK Pertussis Vaccine Market
o France Pertussis Vaccine Market
o Russia Pertussis Vaccine Market
o Italy Pertussis Vaccine Market
o Rest of Europe Pertussis Vaccine Market
o Asia-Pacific
§ Asia-Pacific Pertussis Vaccine Market, By Country
o China Pertussis Vaccine Market
o Japan Pertussis Vaccine Market
o South Korea Pertussis Vaccine Market
o India Pertussis Vaccine Market
o Southeast Asia Pertussis Vaccine Market
o Rest of Asia-Pacific Pertussis Vaccine Market
o South America
§ South America Pertussis Vaccine Market, By Country
o Brazil Pertussis Vaccine Market
o Argentina Pertussis Vaccine Market
o Columbia Pertussis Vaccine Market
o Rest of South America Pertussis Vaccine Market
o Middle East and Africa
§ Middle East and Africa Pertussis Vaccine Market, By Country
o Saudi Arabia Pertussis Vaccine Market
o UAE Pertussis Vaccine Market
o Egypt Pertussis Vaccine Market
o Nigeria Pertussis Vaccine Market
o South Africa Pertussis Vaccine Market
o Rest of MEA Pertussis Vaccine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Pertussis Vaccine Market, By Product Type
5.1. Introduction
5.2. Global Pertussis Vaccine Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Pertussis Vaccine Revenue and Revenue Share by Product Type (2017-2027)
5.3. Tdap Vaccine
5.3.1. Global Tdap Vaccine Revenue and Growth Rate (2017-2027)
5.4. DTaP Vaccine
5.4.1. Global DTaP Vaccine Revenue and Growth Rate (2017-2027)
6. Pertussis Vaccine Market, By Vaccine Type
6.1. Introduction
6.2. Global Pertussis Vaccine Revenue and Market Share by Vaccine Type (2017-2027)
6.2.1. Global Pertussis Vaccine Revenue and Revenue Share by Vaccine Type (2017-2027)
6.3. Acellular Vaccine
6.3.1. Global Acellular Vaccine Revenue and Growth Rate (2017-2027)
6.4. Whole-Cell Vaccine
6.4.1. Global Whole-Cell Vaccine Revenue and Growth Rate (2017-2027)
7. Pertussis Vaccine Market, By End User
7.1. Introduction
7.2. Global Pertussis Vaccine Revenue and Market Share by End User (2017-2027)
7.2.1. Global Pertussis Vaccine Revenue and Revenue Share by End User (2017-2027)
7.3. Vaccination Centers
7.3.1. Global Vaccination Centers Revenue and Growth Rate (2017-2027)
7.4. Clinics
7.4.1. Global Clinics Revenue and Growth Rate (2017-2027)
7.5. Hospitals
7.5.1. Global Hospitals Revenue and Growth Rate (2017-2027)
8. Pertussis Vaccine Market, By Region
8.1. Introduction
8.2. Global Pertussis Vaccine Revenue and Market Share by Regions
8.2.1. Global Pertussis Vaccine Revenue by Regions (2017-2027)
8.3. North America Pertussis Vaccine by Countries
8.3.1. North America Pertussis Vaccine Revenue and Growth Rate (2017-2027)
8.3.2. North America Pertussis Vaccine Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Pertussis Vaccine by Countries
8.4.1. Europe Pertussis Vaccine Revenue and Growth Rate (2017-2027)
8.4.2. Europe Pertussis Vaccine Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Pertussis Vaccine by Countries
8.5.1. Asia-Pacific Pertussis Vaccine Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Pertussis Vaccine Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Pertussis Vaccine by Countries
8.6.1. South America Pertussis Vaccine Revenue and Growth Rate (2017-2027)
8.6.2. South America Pertussis Vaccine Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Pertussis Vaccine by Countries
8.7.1. Middle East and Africa Pertussis Vaccine Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Pertussis Vaccine Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Novartis AG
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Astellas Pharma US, Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Sanofi Pasteur
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Merck Sharp & Dohme Corp.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. GlaxoSmithKline
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Seqirus
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Protein Sciences Corporation
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
10. Pertussis Vaccine Market Forecast (2017-2027)
10.1. Global Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Pertussis Vaccine Market Forecast by Regions (2017-2027)
10.2.1. North America Pertussis Vaccine Market Forecast (2017-2027)
10.2.1.1. United States Pertussis Vaccine Market Forecast (2017-2027)
10.2.1.2. Canada Pertussis Vaccine Market Forecast (2017-2027)
10.2.1.3. Mexico Pertussis Vaccine Market Forecast (2017-2027)
10.2.2. Europe Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.1. Germany Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.2. France Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.3. UK Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.4. Russia Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.5. Italy Pertussis Vaccine Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Pertussis Vaccine Market Forecast (2017-2027)
10.2.3. Asia-Pacific Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.1. China Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.2. Japan Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.3. Korea Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.4. India Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Pertussis Vaccine Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Pertussis Vaccine Market Forecast (2017-2027)
10.2.4. South America Pertussis Vaccine Market Forecast (2017-2027)
10.2.4.1. Brazil Pertussis Vaccine Market Forecast (2017-2027)
10.2.4.2. Argentina Pertussis Vaccine Market Forecast (2017-2027)
10.2.4.3. Columbia Pertussis Vaccine Market Forecast (2017-2027)
10.2.4.4. Rest of South America Pertussis Vaccine Market Forecast (2017-2027)
10.2.5. Middle East and Africa Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.3. Egypt Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.4. Nigeria Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.5. South Africa Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.6. Turkey Pertussis Vaccine Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Pertussis Vaccine Market Forecast (2017-2027)
10.3. Pertussis Vaccine Market Forecast by Product Type (2017-2027)
10.3.1. Pertussis Vaccine Forecast by Product Type (2017-2027)
10.3.2. Pertussis Vaccine Market Share Forecast by Product Type (2017-2027)
10.4. Pertussis Vaccine Market Forecast by Vaccine Type (2017-2027)
10.4.1. Pertussis Vaccine Forecast by Vaccine Type (2017-2027)
10.4.2. Pertussis Vaccine Market Share Forecast by Vaccine Type (2017-2027)
10.5. Pertussis Vaccine Market Forecast by End User (2017-2027)
10.5.1. Pertussis Vaccine Forecast by End User (2017-2027)
10.5.2. Pertussis Vaccine Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Pertussis Vaccine Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Tdap Vaccine Revenue and Growth Rate (2017-2018)
Figure Global DTaP Vaccine Revenue and Growth Rate (2017-2018)
Table Global Pertussis Vaccine Revenue and Revenue Share by Vaccine Type (2017-2018)
Figure Global Acellular Vaccine Revenue and Growth Rate (2017-2018)
Figure Global Whole-Cell Vaccine Revenue and Growth Rate (2017-2018)
Table Global Pertussis Vaccine Revenue and Revenue Share by End User (2017-2018)
Figure Global Vaccination Centers Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Pertussis Vaccine Revenue by Regions (2017-2018)
Figure North America Pertussis Vaccine Growth Rate (2017-2018)
Figure North America Pertussis Vaccine Revenue and Growth Rate (2017-2018)
Figure North America Pertussis Vaccine by Countries (2017-2018)
Figure North America Pertussis Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure United States Pertussis Vaccine Growth Rate (2017-2018)
Figure United States Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Pertussis Vaccine Growth Rate (2017-2018)
Figure Canada Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Pertussis Vaccine Growth Rate (2017-2018)
Figure Mexico Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Pertussis Vaccine Growth Rate (2017-2018)
Figure Europe Pertussis Vaccine Revenue and Growth Rate (2017-2018)
Figure Europe Pertussis Vaccine by Countries (2017-2018)
Figure Europe Pertussis Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Pertussis Vaccine Growth Rate (2017-2018)
Figure Germany Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Pertussis Vaccine Growth Rate (2017-2018)
Figure France Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Pertussis Vaccine Growth Rate (2017-2018)
Figure UK Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Pertussis Vaccine Growth Rate (2017-2018)
Figure Russia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Pertussis Vaccine Growth Rate (2017-2018)
Figure Italy Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Pertussis Vaccine Growth Rate (2017-2018)
Figure Rest of Europe Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Pertussis Vaccine Growth Rate (2017-2018)
Figure Asia-Pacific Pertussis Vaccine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Pertussis Vaccine by Countries (2017-2018)
Figure Asia-Pacific Pertussis Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure China Pertussis Vaccine Growth Rate (2017-2018)
Figure China Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Pertussis Vaccine Growth Rate (2017-2018)
Figure Japan Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Pertussis Vaccine Growth Rate (2017-2018)
Figure Korea Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Pertussis Vaccine Growth Rate (2017-2018)
Figure India Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Pertussis Vaccine Growth Rate (2017-2018)
Figure Southeast Asia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pertussis Vaccine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Pertussis Vaccine Growth Rate (2017-2018)
Figure South America Pertussis Vaccine Revenue and Growth Rate (2017-2018)
Figure South America Pertussis Vaccine by Countries (2017-2018)
Figure South America Pertussis Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Pertussis Vaccine Growth Rate (2017-2018)
Figure Brazil Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Pertussis Vaccine Growth Rate (2017-2018)
Figure Argentina Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Pertussis Vaccine Growth Rate (2017-2018)
Figure Columbia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Pertussis Vaccine Growth Rate (2017-2018)
Figure Rest of South America Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Pertussis Vaccine Growth Rate (2017-2018)
Figure Middle East and Africa Pertussis Vaccine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Pertussis Vaccine by Countries (2017-2018)
Figure Middle East and Africa Pertussis Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Pertussis Vaccine Growth Rate (2017-2018)
Figure Saudi Arabia Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Pertussis Vaccine Growth Rate (2017-2018)
Figure United Arab Emirates Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Pertussis Vaccine Growth Rate (2017-2018)
Figure Egypt Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Pertussis Vaccine Growth Rate (2017-2018)
Figure Nigeria Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Pertussis Vaccine Growth Rate (2017-2018)
Figure South Africa Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Pertussis Vaccine Growth Rate (2017-2018)
Figure Turkey Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pertussis Vaccine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Novartis AG Pertussis Vaccine Financial Overview
Table Astellas Pharma US, Inc. Pertussis Vaccine Financial Overview
Table Sanofi Pasteur Pertussis Vaccine Financial Overview
Table Merck Sharp & Dohme Corp. Pertussis Vaccine Financial Overview
Table GlaxoSmithKline Pertussis Vaccine Financial Overview
Table Seqirus Pertussis Vaccine Financial Overview
Table Protein Sciences Corporation Pertussis Vaccine Financial Overview
Figure Global Pertussis Vaccine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Pertussis Vaccine Market Forecast by Regions (2018-2025)
Figure North America Pertussis Vaccine Market Forecast (2018-2025)
Figure United States Pertussis Vaccine Market Forecast (2018-2025)
Figure Canada Pertussis Vaccine Market Forecast (2018-2025)
Figure Mexico Pertussis Vaccine Market Forecast (2018-2025)
Figure Europe Pertussis Vaccine Market Forecast (2018-2025)
Figure Germany Pertussis Vaccine Market Forecast (2018-2025)
Figure France Pertussis Vaccine Market Forecast (2018-2025)
Figure UK Pertussis Vaccine Market Forecast (2018-2025)
Figure Russia Pertussis Vaccine Market Forecast (2018-2025)
Figure Italy Pertussis Vaccine Market Forecast (2018-2025)
Figure Rest of Europe Pertussis Vaccine Market Forecast (2018-2025)
Figure Asia-Pacific Pertussis Vaccine Market Forecast (2018-2025)
Figure China Pertussis Vaccine Market Forecast (2018-2025)
Figure Japan Pertussis Vaccine Market Forecast (2018-2025)
Figure Korea Pertussis Vaccine Market Forecast (2018-2025)
Figure India Pertussis Vaccine Market Forecast (2018-2025)
Figure Southeast Asia Pertussis Vaccine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Pertussis Vaccine Market Forecast (2018-2025)
Figure South America Pertussis Vaccine Market Forecast (2018-2025)
Figure Brazil Pertussis Vaccine Market Forecast (2018-2025)
Figure Argentina Pertussis Vaccine Market Forecast (2018-2025)
Figure Columbia Pertussis Vaccine Market Forecast (2018-2025)
Figure Rest of South America Pertussis Vaccine Market Forecast (2018-2025)
Figure Middle East and Africa Pertussis Vaccine Market Forecast (2018-2025)
Figure Saudi Arabia Pertussis Vaccine Market Forecast (2018-2025)
Figure United Arab Emirates Pertussis Vaccine Market Forecast (2018-2025)
Figure Egypt Pertussis Vaccine Market Forecast (2018-2025)
Figure Nigeria Pertussis Vaccine Market Forecast (2018-2025)
Figure South Africa Pertussis Vaccine Market Forecast (2018-2025)
Figure Turkey Pertussis Vaccine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Pertussis Vaccine Market Forecast (2018-2025)
Figure Global Pertussis Vaccine Forecast by Product Type (2018-2025)
Figure Global Pertussis Vaccine Market Share Forecast by Product Type (2018-2025)
Figure Global Pertussis Vaccine Forecast by Product Type (2018-2025)
Figure Global Pertussis Vaccine Forecast by Vaccine Type (2018-2025)
Figure Global Pertussis Vaccine Market Share Forecast by Vaccine Type (2018-2025)
Figure Global Pertussis Vaccine Forecast by Vaccine Type (2018-2025)
Figure Global Pertussis Vaccine Forecast by End User (2018-2025)
Figure Global Pertussis Vaccine Market Share Forecast by End User (2018-2025)
Figure Global Pertussis Vaccine Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|